Vit A Plus

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vit A Plus

What is Vit A Plus? Identity, Composition, and Purpose

Property Description
Active ingredient Retinol or Retinyl Palmitate (Vitamin A)
Form Oral Capsule or Oral Solution
Pharmacological class Essential Fat-Soluble Vitamin
Common use Prevention of Vitamin A Deficiency (VAD)
Origin Typically Synthetic

What is the Identity and Class of Vit A Plus?

Vit A Plus is an oral micronutrient supplement primarily administered within public health programs to combat nutritional deficiencies. It belongs to the pharmacological class of essential fat-soluble vitamins.

This specific formulation is designed as a high-dose supplement, often supplied as a small, soft gelatin capsule or an oral liquid solution. This high-concentration format is clinically recognized for its efficiency in rapidly boosting Vitamin A reserves. Its role is distinct from that of daily multivitamins, focusing instead on periodic, preventative dosing for populations deemed at risk.


What is Vit A Plus Composed of?

The primary active component is a stable derivative of Vitamin A, typically Retinol (the International Nonproprietary Name, or INN) or an ester such as Retinyl Palmitate. The active ingredients used in these supplements are predominantly produced through synthetic manufacturing to ensure precise concentration, purity, and stability across diverse environments.

Consistent with fat-soluble vitamin delivery, the final product utilizes an oil-based solution encased in a capsule to maximize absorption. This oil base is a required formulation feature that helps the body effectively absorb and utilize this vital nutrient.


What is the Main Therapeutic Purpose of Vit A Plus?

The core therapeutic purpose of Vit A Plus is the prevention of Vitamin A Deficiency (VAD) and its related severe consequences in vulnerable groups, such as young children. This objective is a cornerstone of global health initiatives and nutritional support programs worldwide.

By providing a concentrated and readily available source of Vitamin A, the supplement helps restore depleted body reserves. Its main goal is to prevent the onset of xerophthalmia (eye diseases that can lead to blindness) and reduce severe morbidity and mortality rates, especially in high-risk regions.

Regulatory References

  1. WHO Guideline on Vitamin A supplementation for children

What side effects are possible with Vit A Plus?

Possible side effects and safety information

The official safety profile for high-dose Vitamin A (Vit A Plus, Retinol/Retinyl Palmitate) is primarily structured around adverse reactions linked to Hypervitaminosis A, a condition resulting from excessive accumulation of the nutrient. The effects are categorized by the body systems they impact and the duration of over-exposure, with documentation sourced from government regulatory labels.

Adverse Reactions by Organ System

The documented adverse reactions associated with toxicity involve several physiological domains, as classified in official documents:

  • Nervous System Disorders: Symptoms may include headache, drowsiness, lethargy, and signs of increased intracranial pressure, such as a transient bulging fontanelle reported in infants [WHO Adverse Events].
  • Gastrointestinal and Dermatological: Reactions include gastrointestinal disturbances like nausea and vomiting, as well as skin changes such as drying, scaling, cracking of the lips, and hair loss (alopecia) [NIH DailyMed Label (AQUASOL A)].
  • Musculoskeletal System: Chronic over-exposure is linked to migratory joint pain (arthralgia) and bone pain [NIH DailyMed Label (AQUASOL A)].

Serious Safety Considerations

Regulatory documentation highlights specific severe safety concerns:

  • Teratogenicity: Use exceeding established guidelines in women who are pregnant or may become pregnant is associated with a risk of fetal malformations [StatPearls/NIH].
  • Hepatotoxicity: High, chronic intake carries a risk of liver damage (hepatotoxicity) [NIH DailyMed Label (AQUASOL A)].

Population and Exposure Constraints

Specific safety constraints are noted for vulnerable groups. Infants and young children are acutely susceptible to toxicity, while patients with severe hepatic or renal impairment have an elevated risk due to inhibited clearance [StatPearls/NIH]. Furthermore, the concomitant use of this supplement with other retinoid-containing products is cautioned against due to the high potential for additive toxicity and increased retinoid exposure [NIH DailyMed Label (TRETINOIN)]. Adverse effects resulting from toxicity are generally documented as reversible upon immediate discontinuation of the supplement.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Vit A Plus (Retinol/Retinyl Palmitate) overdose is defined by the clinical presentations of Hypervitaminosis A, which is classified as both acute and chronic toxicity.

Acute overdose symptoms documented in official labeling include severe headache, vomiting, dizziness, drowsiness, and irritability. Chronic overdose manifestations include alopecia (hair loss), dry skin and mucous membranes, and bone and joint pain.


Documented Severe Outcomes and Required Action

Official documents indicate that overdose may lead to severe systemic outcomes, notably increased intracranial pressure (Pseudotumor Cerebri) and potentially life-threatening hepatic toxicity. Immediate action is required upon suspicion of overdose.

Regulatory authorities mandate that the product must be discontinued immediately, and individuals must seek immediate medical attention or contact a poison control center for any suspected acute overdose or severe symptoms. Management is strictly symptomatic and supportive treatment, as no specific antidote is known. Hospital monitoring and observation may be required to assess neurological status and hepatic function. Official labeling also notes the increased susceptibility to acute toxicity in infants and children.

Therapeutic Uses of Vit A Plus

What Vit A Plus Treats: Main Uses and Benefits

This information is applied across therapeutic domains where additional symptomatic support is needed to address nutritional deficiencies. This supplement is relevant in conditions characterized by periods of heightened symptoms resulting from a lack of this essential nutrient.

It is commonly used to help manage symptom clusters that may become intense or disruptive, such as night blindness and severe dryness of the eyes, which are noticeable manifestations of deficiency. Furthermore, it supports the patient during difficult episodes by easing distress from infectious diseases and plays a role in managing symptoms related to systemic imbalance by assisting with healthy skin and growth in children.

“It is relevant when supportive symptom management is appropriate, particularly during phases of heightened physiological stress.”


Quick Fact: Relief for Vision Symptoms

Quick Fact: Relief for Vision Symptoms

Vit A Plus may assist with managing symptoms that interfere with daily comfort, focusing on conditions where difficulty seeing in low light and dryness of the ocular surface are noticeable manifestations of systemic imbalance. It is commonly used to help with symptoms that interfere with daily functioning.

Regulatory References

  1. NIH MedlinePlus overview of Vitamin A

Eligibility and Restrictions for Use

Who can and cannot use Vit A Plus?

The official eligibility profile for high-dose Vitamin A (Vit A Plus) is defined by stringent population-based rules from regulatory sources, primarily focused on the risks of toxicity.

Populations for whom use is Contraindicated Eligibility Status
Patients with existing Hypervitaminosis A (Vitamin A Toxicity) Contraindicated
Patients using other oral retinoids (e.g., isotretinoin, acitretin) Contraindicated
Women who are pregnant or planning to become pregnant (at high doses) Contraindicated (Teratogenic Risk)
Patients with severe Hepatic or Renal Impairment (Liver/Kidney disease) Contraindicated

Age-Related Eligibility: Routine preventative use is established for children aged 6 to 59 months in deficiency-endemic areas. Use in infants under 6 months is generally not recommended by public health guidelines.

Condition-Based Eligibility: Use is permitted and often required for patients with diagnosed deficiency or malabsorption syndromes.

Pregnancy and Lactation: High-dose use is contraindicated in pregnancy. Postpartum high-dose supplementation for maternal repletion is reserved for specific deficiency-endemic settings; routine use during breastfeeding is not recommended.

What should I know about interactions with other medicines?

Vit A Plus Interactions with other medicines and products

The interaction profile for Vit A Plus (Retinyl Palmitate/Retinol) is structured by officially documented constraints arising from additive effects and pharmacokinetic interference. This profile is derived entirely from government regulatory documents and health authority monographs.

Interacting Substance Category Formal Regulatory Restriction Official Interaction Outcome
Systemic Retinoids (e.g., Isotretinoin) Co-administration is formally restricted. Additive retinoid effects leading to systemic toxicity (Hypervitaminosis A).
Tetracycline-Class Antibiotics (e.g., Doxycycline) Co-administration is advised against. Increased risk of Intracranial Hypertension (Pseudotumor Cerebri).
Anticoagulants (e.g., Warfarin) Use requires monitoring due to interaction. May increase the risk of bleeding.

This interaction structure establishes restrictions designed to mitigate pharmacodynamic risk. Separately, the profile addresses Modification of Gastrointestinal Absorption. Bile Acid Sequestrants (e.g., Cholestyramine) and Lipase Inhibitors (e.g., Orlistat) are officially documented to decrease the absorption and overall systemic exposure of the fat-soluble vitamin. To counteract this, regulatory information includes a timing-based constraint, which requires the vitamin to be taken separated by several hours from these agents. Furthermore, co-administration with any other Vitamin A supplements is a formal restriction intended to prevent the cumulative intake from exceeding established safe limits.

Mechanism of Action

The mechanism of action for Vit A Plus (Retinol/Retinyl Palmitate) is defined by its role as a precursor to intracellular ligands, orchestrating two distinct and essential physiological processes: transcriptional regulation and specialized visual function.


Transcriptional Modulation and Cellular Integrity

The active metabolite, Retinoic Acid (RA), functions as an agonist for Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs). These receptors bind to DNA, directly modulating the transcription (expression) of genes critical for cell development and differentiation. This mechanism supports the correct development and structural configuration of epithelial tissues, such as mucous membranes, and modulates the differentiation and activity of immune cells.


Regeneration of Visual Photopigments

A separate, non-transcriptional pathway involves the metabolite 11-cis-retinal, which is a necessary component for the formation of Rhodopsin, the light-sensitive pigment in the retina's photoreceptor cells. This action is critical for the continuous regeneration of the visual cycle, which supplies the necessary chromophore for the light detection process in photoreceptor cells.


Precursor Activation and Constraints

The administered precursor molecule must undergo obligatory enzymatic conversion via dehydrogenase enzymes to yield the active Retinoic Acid and Retinal metabolites. This metabolic cascade, coupled with the dependence on systemic Retinol-Binding Proteins (RBP4) for transport, dictates the molecular availability and constrains the final extent of receptor binding.

Dosage and Administration Information

The administration of Vit A Plus (High-Dose Vitamin A) is defined by its use as an oral micronutrient supplement within standardized public health protocols. This formulation is designed for intermittent dosing, a pattern that distinguishes it from continuous daily vitamin intake. Standard protocols specify that a single, high-concentration dose be administered every four to six months to replenish body reserves, and this frequency must not be exceeded.

Administration is accomplished via the oral route using either a soft gelatin capsule or an oral solution. A key administration condition is that the supplement must be taken with or immediately following a meal containing fat, which is necessary to facilitate the optimal absorption of this fat-soluble nutrient. For infants and young children, established administration guidelines specify that the capsule may be cut or punctured to allow the oil contents to be squeezed directly into the mouth.

Dosing is strictly stratified by age and physiological state as detailed in technical protocols. The use of high-dose Vitamin A in reproductive-aged women is generally restricted to the postpartum period, which defines a specific use constraint within its official administration protocol.

Target Population Official Single Dose Frequency Pattern
Infants (6–11 months) 100,000 IU Intermittent, every 4–6 months
Children (12–59 months) 200,000 IU Intermittent, every 4–6 months
Lactating Women (Postpartum) 200,000 IU Single dose, postpartum

Recent Clinical Evidence

Research Evidence / Overview of Studies for Vit A Plus

Research Evidence for Outcomes Related to Vitamin A Deficiency

The evidence base for high-dose Vitamin A supplementation is built upon Randomized Controlled Trials (RCTs) and Systematic Reviews. This research has examined the association between the supplement and adverse health outcomes in populations facing nutritional deficiencies, primarily utilizing large-scale, controlled designs to study group patterns related to deficiency and associated health risks.

Study Endpoints: Mortality and Serious Infectious Disease

Researchers studied high-level outcomes related to physiological strain. Specifically, research examined all-cause mortality and cause-specific mortality associated with common childhood illnesses like diarrhoea and measles. Data show patterns related to these mortality measurements that were observed in the studied populations. Research also contributes to the evidence landscape by describing symptom patterns related to night blindness and severe eye dryness.

Long-term Follow-up and Study Duration

The largest studies utilized observation periods generally extending up to one year for assessing mortality. The long-term effects are not fully established. While research was evaluated in studies lasting up to one year, the durability of any observed response over many years is an area where certainty remains low.

Evidence in Specific Child Populations

Findings are specific to the populations studied—predominantly children aged 6 to 59 months residing in areas with endemic Vitamin A Deficiency. Subgroup analysis was also observed in children with Severe Acute Malnutrition (SAM). Few data are available for other populations, such as healthy older children or adults, leaving findings for those groups uncertain.

What is Still Uncertain About the Research

Evidence highlights areas of uncertainty. For instance, findings were mixed across different studies when evaluating outcomes related to Lower Respiratory Tract Infections (LRTIs), such as pneumonia. Furthermore, research is ongoing, but whether administering the supplement to children who are considered retinol-sufficient at baseline is an area where evidence is limited and subgroup findings are uncertain. Comparative evidence regarding various dosing regimens is also lacking.

Frequently Asked Questions (FAQ)

Common questions about Vit A Plus (FAQ)

Q: Is Vit A Plus the same as just taking a regular Vitamin A pill?

Official information indicates that Vit A Plus is defined by its use as a high-concentration supplement administered as an intermittent dose. This dosing pattern, typically given every four to six months, distinguishes it from a continuous daily vitamin intake that is often found in regular multivitamin pills.


Q: Are there any common side effects people report when first starting Vit A Plus?

Regulatory documents list adverse reactions that are linked to Vitamin A toxicity or excessive accumulation. These documented effects can include symptoms like headache, nausea, and vomiting. Experiencing adverse effects should prompt an evaluation by a healthcare professional.


Q: Why do some people say Vit A Plus gave them an upset stomach?

Gastrointestinal disturbances, specifically nausea and vomiting, are documented as possible adverse reactions in official safety information. These symptoms are generally associated with excessive intake, but can be reported by individuals.


Q: Can Vit A Plus cause any changes to skin or hair?

Official safety documents associated with toxicity list several dermatological reactions. These can include skin changes such as drying, scaling, cracking of the lips, and hair loss (alopecia). These effects are often linked to chronic or high accumulation of the nutrient.


Q: What does the research say about Vit A Plus for eye health?

Systematic reviews describe symptom patterns related to night blindness and severe eye dryness in populations with a nutritional deficiency. The supplement's active form is critical for the continuous regeneration of the visual cycle, which is required for light detection in the eye.


Q: Can I consume alcohol moderately while taking Vit A Plus?

Regulatory safety information indicates a risk of liver damage (hepatotoxicity) linked to high or chronic intake of Vitamin A. While specific consumption limits for alcohol are generally not provided in official documents, heavy or chronic alcohol use may narrow the therapeutic window and potentially increase this risk.


Q: Does Vit A Plus affect sleep patterns?

Official documents on adverse reactions list drowsiness and lethargy under Nervous System Disorders, which are formally documented side effects associated with toxicity. Regulatory labels do not formally describe general effects on sleep patterns outside of this context.


Q: How does the body absorb and process Vit A Plus compared to diet-based Vitamin A?

The supplement is formulated as an oil-based solution and is required to be taken with a meal containing fat to maximize absorption. Once absorbed, it relies on specialized transport proteins and requires the body to perform enzymatic conversion to make the vitamin active.


Q: Is it normal to feel a bit tired when starting a new supplement like Vit A Plus?

Official safety information lists symptoms of drowsiness and lethargy as side effects of toxicity (excessive accumulation). These are the only contexts in which these effects are formally documented in regulatory safety data.


Q: What happens in the body when Vit A Plus starts to 'work'?

Once administered, the supplement is converted into two active forms. One form helps modulate gene expression critical for cell development and immune activity, and the other is essential for the continuous regeneration of the visual cycle in the eye.


Q: Can Vit A Plus be taken at the same time as my daily multivitamin?

Official regulatory restrictions mandate that co-administration with any other Vitamin A supplements is restricted. This rule is intended to prevent the cumulative intake from exceeding established safe limits and avoid toxicity.


Q: Is it better to take Vit A Plus in the morning or at night?

Regulatory instructions state that the supplement must be taken with or immediately following a meal containing fat to facilitate optimal absorption. Official information does not specify whether morning or night is superior, only that it must be taken with a meal.


Q: What happens if I forget to take a dose of Vit A Plus?

General vitamin dosing information suggests that a missed dose may be taken as soon as it is remembered. However, if it is close to the time for the next scheduled dose, the missed dose may be skipped to help avoid taking a double dose.


Q: How long does the effect of one dose of Vit A Plus typically last in the body?

The formulation is defined by its use as an intermittent dose administered every four to six months. This frequency is established in official guidelines to effectively replenish the body’s Vitamin A reserves.


Q: Is Vit A Plus often prescribed or is it usually available over-the-counter?

Official product information identifies Vit A Plus as an oral micronutrient supplement. It is primarily administered within standardized public health programs to address nutritional deficiencies, rather than being routinely prescribed by an individual doctor.


Q: Can I crush or open the capsule of Vit A Plus if I have trouble swallowing pills?

Official administration guidelines specify that for infants and young children, the capsule may be cut or punctured to squeeze the oil contents directly into the mouth. This instruction is specifically for infants and young children; official information does not extend this guidance to other populations.


Q: Does the efficacy of Vit A Plus decrease if it's exposed to heat or light?

Regulatory guidelines for storage mandate specific protection measures. The product must be kept away from excess heat, moisture, and must be protected from light to maintain its stability and effectiveness.


Q: Is Vit A Plus suitable for vegetarians or vegans?

The supplement is often provided as a soft gelatin capsule. While the active ingredient is typically synthesized, the capsule itself often contains animal-derived gelatin. Individuals should check the capsule's source material, as gelatin is often derived from animal products.


Q: What is the main benefit of Vit A Plus for the immune system?

The active metabolite of the supplement, Retinoic Acid, plays a role in the immune system. Official information states that this metabolite modulates the differentiation and activity of immune cells in the body.


Q: What are the signs of taking too much Vit A Plus?

Official safety data lists documented symptoms of acute toxicity, which can include headache, nausea, vomiting, and signs of increased intracranial pressure. In infants, a transient bulging fontanelle has also been reported.


Q: Is there a specific time period after which I should stop taking Vit A Plus?

Official regulatory instructions define the supplement's use as intermittent dosing administered every four to six months. This frequency must not be exceeded, and the product is not intended for continuous daily or long-term use.


Q: Is Vit A Plus available in liquid or chewable form?

The supplement is officially available in two primary forms: an Oral Capsule (often a soft gelatin capsule) or an Oral Solution (liquid form).

How should Vit A Plus be stored and disposed of?

How to Store and Dispose of Vit A Plus

Official regulatory guidelines mandate specific conditions for storing and disposing of Vit A Plus (Vitamin A supplements) to maintain its stability and prevent degradation.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 15 to 30 C (59 to 86 F). Do not freeze the product.
Protection Keep away from excess heat and moisture. The product must be protected from light.
Packaging Keep the medicine in its original container and ensure it is tightly closed and stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Vit A Plus must be discarded according to the instructions on the package or as directed by a pharmacist. Medicines should not be disposed of by flushing them down a toilet or pouring them down a sink, but rather handled according to local regulatory requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vit A Plus found in:

A-Z Index: